Results 231 to 240 of about 117,049 (245)
Some of the next articles are maybe not open access.

Studies on the Pharmacokinetics and Metabolism of Prednicarbate after Cutaneous and Oral Administration

Skin Pharmacology and Physiology, 1993
Prednicarbate (PC) is a nonhalogenated derivative of prednisolone which is used for the local treatment of corticoid-sensitive skin diseases. In this study, the pharmacokinetics and the metabolism of PC in humans are investigated after cutaneous ointment application (75 mg PC) and after systemic oral administration (40 mg PC) in 8 healthy volunteers ...
Th. Höhler   +5 more
openaire   +2 more sources

Cutaneous and ocular adverse reactions in a dog following meloxicam administration

Veterinary Dermatology, 2007
AbstractThe present report addresses the development of cutaneous and ocular reactions possibly related to meloxicam administration in a dog.Based on clinical signs and absence of laboratory data compatible with the other differential diagnoses considered, the possibility of an adverse drug reaction (ADR) due to meloxicam was considered.
A. J. A. Ferreira   +4 more
openaire   +3 more sources

Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in Equidae

Journal of the American Veterinary Medical Association, 1994
Summary Twenty-seven horses (and 1 mule) with 32 histologically confirmed cutaneous tumors were studied to evaluate the effects of intratumoral injection of cisplatin initiated at the time of surgery. As a result of surgery, 9 of the wounds were closed primarily (5 sarcoids, 4 carcinomas) and 23 were left open to granulate (16 sarcoids, 6 carcinomas, 1
A P, Théon, J R, Pascoe, D M, Meagher
openaire   +2 more sources

Hypotension and cutaneous reactions associated with intravenous administration of etoposide in the dog

American Journal of Veterinary Research, 1988
SUMMARY A study was undertaken to determine the pressor and toxic effects of etoposide, an antineoplastic agent, when administered iv in 0.9% sodium chloride solution (0.4 mg of etoposide/ml) over a 30-minute period to dogs at a dosage of 40 mg/m2 of body surface. On day 1, 6 adult German Shorthaired Pointers were anesthetized with halothane, and blood
G K, Ogilvie   +4 more
openaire   +2 more sources

Kinetics and bioavailability of N-nitrosodiethanolamine after intravenous and cutaneous administration to rats

Food and Chemical Toxicology, 1984
Male CD-COBS rats were given N-nitrosodiethanolamine (NDELA) by intravenous or cutaneous administration at a dose of 5 mg/kg. Blood and liver were analysed for NDELA at various times after administration. The excretion of unchanged NDELA and its acidic metabolite N-(2-hydroxyethyl)-N-carboxymethylnitrosamine (ECMN) was determined in urine for 24 hr ...
Roberto Fanelli   +4 more
openaire   +3 more sources

A CUTANEOUS ANAPHYLACTIC REACTION AS A CONTRA-INDICATION TO THE ADMINISTRATION OF ANTITOXIN

JAMA: The Journal of the American Medical Association, 1910
Almost every physician who frequently has occasion to administer antitoxic serum has seen more or less serious symptoms follow the injection in individuals who months or even years previously have received serum. These symptoms usually develop within twenty-four hours, often in less time, and may be slight, consisting of one or several of the following:
openaire   +2 more sources

Cutaneous toxicity following administration of dactinomycin

Medical and Pediatric Oncology, 1998
Penelope Brock   +3 more
openaire   +2 more sources

Cutaneous reaction after intravenous administration of medetomidine?

Veterinary Anaesthesia and Analgesia, 2011
Andrea Volk   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy